GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a substantial shift in how we handle type 2 diabetes . These injectable drugs function to imitating the body’s inherent GLP-1 process, https://mariyahgwtq025904.blogripley.com/42766364/glp-1-a-major-advance-in-blood-sugar-management